Page last updated: 2024-12-06

glycarbylamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID65745
CHEMBL ID498980
SCHEMBL ID343999
MeSH IDM0046273

Synonyms (20)

Synonym
glycarbylamide
1h-imidazole-4,5-dicarboxamide
83-39-6
CHEMBL498980
glycalbylamide
imidazole-4,5-dicarboxamide
I0435
ai3-52513
glycamide
4,5-imidazoledicarboxamide
AKOS015854522
SCHEMBL343999
DTXSID20232109
1h-imidazole-4,5-dicarboxamide #
mfcd00047022
glycarbylamide, pestanal(r), analytical standard
AS-61400
FT-0752016
D91151
CS-0149985
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID444559Inhibition of Bacillus anthracis DHPS expressed in Escherichia coli BL21 (DE3) at 500 uM after 30 mins2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Structural studies of pterin-based inhibitors of dihydropteroate synthase.
AID409603Inhibition of human aquaporin 4 M23 isoform expressed in Xenopus laevis oocytes at 20 uM2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Identification of aquaporin 4 inhibitors using in vitro and in silico methods.
AID444560Inhibition of Bacillus anthracis DHPS expressed in Escherichia coli BL21 (DE3) after 30 mins2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Structural studies of pterin-based inhibitors of dihydropteroate synthase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (25.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]